Pediatric Neurology
Volume 24, Issue 5 , Pages 357-360, May 2001

Expression of calbindin and calretinin in the human ganglionic eminence

  • Norbert Ulfig, MD

      Affiliations

    • Department of Anatomy; Neuroembryonic Research Laboratory; University of Rostock; Rostock, Germany
    • Corresponding Author InformationCommunications should be addressed to: Dr. Ulfig; Neuroembryonic Research Laboratory; Department of Anatomy; University of Rostock; Gertrudenstr. 9; 18055 Rostock, Germany

Received 1 August 2000; accepted 14 February 2001.

Abstract 

The conspicuous ganglionic eminence representing a part of the telencephalic proliferative zone contains neuroblasts of the striatum. Recently it has been found to contribute significantly to the class of interneurons in the cerebral cortex. Subpopulations of cortical interneurons contain calretinin and calbindin. The expression of calretinin and calbindin in the ganglionic eminence and adjacent areas has been investigated immunocytochemically during fetal development using the brains of 10 infants ranging in age from 16 and 26 weeks gestation. Between 16 and 20 weeks gestation, numerous calretinin-immunreactive nerve cells are found in the ganglionic eminence, particularly in the mantle and the intermediate zones. The number of calretinin-immunoreactive cells decreases gradually from 21 weeks gestation onwards. Larger calbindin-immunoreactive cells are seen in the ganglionic eminence, and their number increases from 20 weeks gestation in the mantle zone. These results may indicate that calretinin-immunoreactive precursor cells, found in the ganglionic eminence, tangentially migrate toward the cortex. Moreover, the mantle zone displaying a specific calretinin and calbindin immunolabeling may represent an intermediate target for outgrowing axons. The findings are discussed with regard to central nervous system complications in preterm infants involving the ganglionic eminence.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(01)00263-6

Pediatric Neurology
Volume 24, Issue 5 , Pages 357-360, May 2001